… to native GLP-1 and activate the GLP-1 receptor. However, in contrast with native GLP-1, …
individual characteristics and major differences between the various GLP-1 receptor agonists …

… receptor agonists (GLP-1 RAs) over the past decade, incretin therapy has become established
as an important treatment … This review focuses on the use of GLP-1 RAs in the treatment of …

… For example, the μ-opioid receptor agonist oliceridine does not … An agonist acting at the
angiotensin II type 1 receptor has … the balanced agonist acting at this receptor. For the 5-HT 1A …

… : Dopamine agonists (DA) are a class of agents which directly stimulate dopamine receptors
… of recent literature evidences, would help clinician in the management of treatment with DA. …

… The current success of agonists at muscarinic acetylcholine receptors in the treatment of …
In this case, it would be important for individualized treatment to find specific predictors of …

… used dopamine receptor agonists include pramipexole, … receptor agonists and genomics
mainly focus on the effect of gene polymorphism on the efficacy of dopamine receptor agonists. …

… randomised comparison between a systemic treatment and an LHRH agonist. In some trials…
the treatments were with an LHRH agonist. The randomised addition of an LHRH agonist …

… fenfluramine as a treatment for seizures in Dravet syndrome. This concept was successfully
evaluated in a zebrafish model and led to a Phase 3 trial of fenfluramine to treat seizures in …

… In the following, we will briefly sum up the current treatment regimens and the pathogenic
basis of anti-fibrotic properties of specific treatments in hepatic fibrosis based on either …

… level or coupling efficiency in particular tissues as a biomarker for selecting patient
subpopulations that would benefit most from treatment with a CB 1 /CB 2 receptor partial agonist. …